Evidence map›Paper›PMID 31727019›Full record

Trial reportBMC cancer2019

Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.

Pieter D de Veij Mestdagh, Willem H Schreuder, Wouter V Vogel, Maarten L Donswijk, Eric van Werkhoven, Jacqueline E van der Wal, Richard Dirven, Baris Karakullukcu, Jan-Jakob Sonke, Michiel W M van den Brekel and 2 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03968679 (Mapping of Sentinel Lymph Node Drainage Using SPECT/CT to Tailor Highly Selective Elective Nodal Irradiation in Node-negative Neck of Patients With Head and Neck Cancer), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03968679 naactive not recruitingnot on this map

Mapping of Sentinel Lymph Node Drainage Using SPECT/CT to Tailor Highly Selective Elective Nodal Irradiation in Node-negative Neck of Patients With Head and Neck Cancer

TypeinterventionalSponsorThe Netherlands Cancer InstituteRan2019 to 2028Enrolled90ConditionsHead and Neck CancerArmsUnilateral elective nodal irradiation
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Trial
  4. From technical feasibility to clinical validation: the next step for SPECT/CT-guided elective nodal irradiation.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Unilateral Neck Treatment with either Surgery and/or Radiotherapy for Squamous Cell Carcinoma for the Tonsil.ORL; journal for oto-rhino-laryngology and its related specialties · 2024
    Article
  9. Review
  10. Article
  11. Evaluating contralateral neck failure in patients with lateralized OPSCC treated with transoral robotic surgery and neck management based on pre-operative SPECT-CT lymphatic mapping.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Advantages of Sentinel Lymph Node Mapping by Single Photon Emission Computed Tomography/Computed Tomography in Early-Stage Malignant Head-and-Neck Skin Tumors.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Pieter D de Veij MestdaghDepartment of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. p.d.veij@nki.nl.ORCID http://orcid.org/0000-0003-0894-1510
Willem H SchreuderDepartment of Head and Neck Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Wouter V VogelDepartment of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.
Maarten L DonswijkDepartment of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Eric van WerkhovenDepartment of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Jacqueline E van der WalDepartment of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Richard DirvenDepartment of Head and Neck Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Baris KarakullukcuDepartment of Head and Neck Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Jan-Jakob SonkeDepartment of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.
Michiel W M van den BrekelDepartment of Head and Neck Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Corrie A M MarijnenDepartment of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.
Abrahim Al-MamganiDepartment of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands.
The Netherlands Cancer Institute · NL

Funding

LSH-TKI Foundation LSHM15036
6 · The paper itself

Abstract

backgroundThe majority of patients with head and neck squamous cell carcinoma (HNSCC) receive bilateral elective nodal irradiation (ENI), in order to reduce the risk of regional failure. Bilateral ENI, as compared to unilateral ENI, is associated with higher incidence of acute and late radiation-induced toxicity with subsequent deterioration of quality of life. Increasing evidence that the incidence of contralateral regional failure (cRF) in lateralized HNSCC is very low (< 10%) suggests that it can be justified to treat selected patients unilaterally. This trial aims to minimize the proportion of patients that undergo bilateral ENI, by using lymph drainage mapping by SPECT/CT to select patients with a minimal risk of contralateral nodal failure for unilateral elective nodal irradiation.

methodsIn this one-armed, single-center prospective trial, patients with primary T1-4 N0-2b HNSCC of the oral cavity, oropharynx, larynx (except T1 glottic) or hypopharynx, not extending beyond the midline and planned for primary (chemo) radiotherapy, are eligible. After DISCUSSION: This single-center prospective trial aims to reduce the incidence and duration of radiation-related toxicities and improve quality of life of HNSCC patients, by using lymph drainage mapping by SPECT/CT to select patients with a minimal risk of contralateral nodal failure for unilateral elective nodal irradiation.

trial registrationClinicalTrials.gov Identifier: NCT03968679, date of registration: May 30, 2019.

Indexed as

Single Photon Emission Computed Tomography Computed TomographyAdultAgedDrainageFemaleHumansLymphatic MetastasisLymph Node ExcisionMaleMiddle AgedNeoplasm StagingQuality of LifeRadiopharmaceuticalsSentinel Lymph NodeSentinel Lymph Node BiopsySquamous Cell Carcinoma of Head and NeckRadiopharmaceuticalsBilateral elective irradiationHead and neck cancerLymph drainage mappingSentinel nodeUnilateral elective irradiation

Identifiers

PMID31727019
PMCPMC6857144
OpenAlexW2985433212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.